Key evidence supporting the notion came from the SELECT trial, which included 17,604 participants aged 45 and older from over 800 locations, recently demonstrated that weekly subcutaneous injections of 2.4 mg of semaglutide significantly reduced MACEs by 20% compared to a placebo in overweight and obese individuals with existing atherosclerotic CVD but no diabetes [26]
[25] Re-imagined as "Axe-Assassin Albertson", the project revolves around a post-apocalyptic backstory in which an Artificial Intelligence in the year 2122 attempts to restore the missing soundtrack to Hamilton by analyzing the lips of the performers
Supports Nutrient Metabolism Glutathione, often referred to as the bodys master antioxidant, plays a crucial role in the metabolism of nutrients
North Carolinas State Health Plan ended coverage in April 2024 after trustees deemed costs unsustainable. West Virginia paused its 1,000-member pilot when spending hit $1.4 million a month
However, the game changer is the 171-day half-life, suggesting they may come out with a once-a-month injection compared to the weekly injections for the incumbents
If Your GLP-1 Isn't Working: A Genetic Checklist If you are currently on a GLP-1 medication and not seeing the results you expected, the following genetic variants are the most clinically relevant starting points for a conversation with your healthcare provider: TCF7L2 status Is your endogenous incretin pathway functioning differently at the genetic level, affecting how much exogenous GLP-1 benefit is available on top of your baseline